Abstract:Author(s): Wang, Ying | Advisor(s): Tidball, James G | Abstract: Skeletal muscle undergoes progressive mass loss, termed sarcopenia, and increased accumulation of fibrotic tissue during aging, which reduces the life quality of the elderly and causes significant economic burden on healthcare services of society. The importance of the immune system, especially myeloid cells, in modulating muscle growth and regeneration following injury suggests that myeloid cells may also have significant influences on sarcopenia and muscle fibrosis during aging. In this investigation, we studied the regulatory interactions between myeloid cells and skeletal muscle during aging. We found that muscle aging is associated with increased number of anti-inflammatory M2a macrophages that can increase muscle fibrosis. Expression of a muscle-specific transgene of nNOS prevented the age-related increases in M2a macrophage and reduced fibrosis in aging muscle. We then tested whether aging of myeloid cells contributes to the age-related increases in M2a macrophages and the associated increases in fibrosis. Transplantation of young bone marrow cells into old mice resulted in fewer M2a macrophages and less accumulation of collagen compared to age-matched, non-transplant mice. We also found that transplantation of young bone marrow cells into old mice prevented sarcopenia. On the other hand, muscles of young mice receiving old bone marrow cells showed decreased numbers of muscle stem cells, called satellite cells, and increased numbers of fibrogenic-converted satellite cells. In vitro, media conditioned by young, but not old, bone marrow-derived macrophages increased muscle cell proliferation. These data suggest that aging of myeloid cells promotes the shift of satellites cell from a myogenic lineage to a more fibrogenic lineage during aging, and contributes to sarcopenia and muscle fibrosis. However, both the nNOS transgene and the heterochronic bone marrow transplantation can also affect muscle aging through unknown mechanisms other than changes in myeloid cells. To specifically manipulate the myeloid cell population, we designed a mouse line with a myeloid-cell-specific mutation of transcription factor Sfpi1 which specifically reduced the number of M2 macrophages in muscle. Myeloid-cell-specific mutation of Sfpi1 prevented sarcopenia and age-related muscle fibrosis, strongly suggesting that muscle aging is at least partly attributable to myeloid cells. Previous studies in our lab and by other groups suggested that tumor necrotic factor-alpha (TNFα) is a macrophage-derived factor that may contribute significantly to muscle aging. We found that systemic TNFα knockout increased satellite cell fusion into muscle fibers in old muscle and prevented sarcopenia. Furthermore, we observed that transplantation of wild-type bone marrow cells into TNFα knockout mice induced sarcopenia and reduced muscle cell fusion, indicating that TNFα secreted by myeloid cells contributes significantly to the reduction of satellite cell myogenic capacity during aging and causes sarcopenia. Overall, our findings provide insight into mechanisms of muscle aging and the regulatory interactions between myeloid cells and skeletal muscle during aging.

[Research progress on the role of regulatory T cells/Th17 cells balance in muscle-bone degeneration and reconstruction]

Research Advances in Muscle Stem Cells and Sarcopenia

[Research Progress on the Regulatory Cell Death of Osteoblasts in Periodontitis].

Regulatory T cells as a potent target for controlling bone loss.

Type 17 T-helper Cells Might Be a Promising Therapeutic Target for Osteoporosis.

Regulatory T cells in skeletal muscle repair and regeneration: recent insights

The balance between helper T 17 and regulatory T cells in osteoimmunology and relevant research progress on bone tissue engineering

Osteoimmunology: The correlation between osteoclasts and the Th17/Treg balance in osteoporosis

Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases

Immunometabolism of macrophages regulates skeletal muscle regeneration

Identification of Novel Pathways and Immune Profiles Related to Sarcopenia

MicroRNA-Regulated Proinflammatory Cytokines in Sarcopenia

Integrating Transcriptomic and Proteomic Data for a Comprehensive Molecular Perspective on the Association between Sarcopenia and Osteoporosis

Bidirectional crosstalk between bone and muscle: the role of RANKL pathway in osteosarcopenia

Regulatory Interactions Between Myeloid Cells and Skeletal Muscle During Aging

Association of Sarcopenia with Osteoporosis: Research and Application

Sarcopenic obesity and osteoporosis: Research progress and hot spots

Th17 and Treg cells in bone related diseases.

Characterizing the skeletal muscle immune microenvironment for sarcopenia: insights from transcriptome analysis and histological validation

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

Deciphering Immune Landscape Remodeling Unravels the Underlying Mechanism for Synchronized Muscle and Bone Aging